Unsure why the comments above are so negative. Nice to take the win, as it is and as they come.
Safety profile for a rare disease is so very important - potentially enough data to take it to the regulators given its safety profile, positive outcomes and rare instances of the disease - can we skip P3?
Unsure why the comments above are so negative. Nice to take the...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.010(3.51%) |
Mkt cap ! $96.19M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 27.0¢ | $45.01K | 159.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17942 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 9634 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
-0.010 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 29.0¢ | 27.0¢ | 41613 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| PAR (ASX) Chart |